-
TRPV1+ Sensory Nerves Suppress Inflammation
2026-09-26
Song and colleagues report that stimulating TRPV1+ sensory afferents at the nape engages brainstem and autonomic pathways that suppress systemic inflammatory responses. The study links peripheral sensory input to catecholamine release and splenic gene-expression changes, while highlighting important limits on generalizing this neural mechanism to other inflammatory models.
-
MK-571 (L-660,711): Assay Workflows
2026-09-25
Use MK-571 to test cysteinyl leukotriene receptor signaling in functional airway models, while keeping its separate MRP1 activity in view. This workflow pairs practical dosing and vehicle controls with a careful comparison to a recent study of transporter-mediated changes in quercetin exposure.
-
RNAi Reveals SARS-CoV-2 Release Factors
2026-09-25
Kerr et al. used an arrayed RNA interference screen and virus-production measurements at two timepoints to identify host pathways that support SARS-CoV-2 replication, including vesicle-mediated transport linked to viral release. Validation across the original virus and Delta and Omicron variants, together with inhibition of Rab11a-mediated cargo delivery by CDKI-73, points to host-directed antiviral hypotheses while leaving important questions about specificity and therapeutic transferability.
-
Parthenolide and ROS-Linked Apoptosis in Lymphoid Cancer
2026-09-24
Across seven lymphoid malignancy cell lines, parthenolide reduced resazurin-measured metabolic activity and was associated with apoptosis, increased reactive oxygen species, glutathione depletion, and loss of mitochondrial membrane potential. The study’s value lies in combining this cross-disease cell panel with redox and cell-death measurements, while its in vitro findings call for careful interpretation of metabolic readouts and further mechanistic validation.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-09-24
Azadi and David examined how PLGA nanoparticle size and surface modification affect uptake by human corneal epithelial cells in a model that includes simulated mucosal conditions. Their results identify energy-dependent endocytosis—especially macropinocytosis and caveolae-mediated uptake—as dominant routes, while showing that uptake depends on both particle size and surface chemistry.
-
Gentamycin Sulfate in Resistance Assay Design
2026-09-23
Discover how Gentamycin Sulfate can function as a mechanistic phenotype probe in bacterial protein synthesis research and plasmid-mediated resistance studies. This guide translates recent carbapenem-resistant Enterobacter cloacae findings into practical assay design, controls, and interpretation strategies.
-
Dinaciclib: A Temporal CDK Perturbation Tool
2026-09-23
Dinaciclib (SCH727965) can do more than suppress proliferation: it enables time-resolved analysis of how CDK activity, apoptosis, and tissue mechanics interact. This article translates a 2026 Drosophila boundary study into a cautious, mechanics-aware framework for cancer research.
-
BBB Permeability Prediction with Lysosomal Correction
2026-09-22
The reference study develops a high-throughput surrogate blood-brain barrier model by combining LLC-PK1-MOCK and LLC-PK1-MDR1 Transwell cultures with a lysosomal trapping correction. Its correlation with unbound brain-to-plasma distribution and successful validation across structurally diverse compounds support a practical workflow for prioritizing CNS drug candidates before extensive in vivo testing.
-
Transcription Condensates Safeguard Genome Stability
2026-09-21
Marmolejo and colleagues show that transcription condensates at histone locus bodies are formed and dissolved at defined points in S phase by cell-cycle and checkpoint kinases. This mechanism coordinates linker histone expression with DNA replication, revealing how condensate timing prevents genome-wide DNA damage.
-
Necrostatin-1: RIP1 Kinase Inhibitor Workflows
2026-09-21
Learn how to use Necrostatin-1 as a mechanistic probe for necroptosis, RIP1 kinase signaling, inflammatory injury, and acute kidney injury research. This workflow-focused guide connects dose selection, orthogonal validation, ferroptosis-aware interpretation, and troubleshooting for more reproducible experiments.
-
Notch Inhibition Sensitizes TNBC to Checkpoint Blockade
2026-09-20
Shen et al. show that aberrant Notch activity in triple-negative breast cancer reshapes the tumor immune microenvironment through cytokine-dependent recruitment of tumor-associated macrophages. Their preclinical data indicate that suppressing this program before immune checkpoint blockade can increase cytotoxic T-cell activity and markedly reduce lung metastasis.
-
ETS1–SENP2 Control of Mitophagy in BPD
2026-09-19
The reference study identifies ETS1 as a transcriptional regulator of mitochondrial quality control in hyperoxia-induced bronchopulmonary dysplasia, connecting SENP2 expression with FUNDC1 deSUMOylation, HSPA8 binding, and FUNDC1 degradation. Its findings clarify a SUMO-regulated mitophagy pathway, while also defining important limits for translating this mechanism into chemical-inhibitor studies.
-
Protease Inhibitor Cocktail: EDTA-Free Use
2026-09-19
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during protein extraction and downstream assays, including Western blotting, co-immunoprecipitation, and kinase workflows. Its EDTA-free composition suits divalent-cation-sensitive applications, but it should not be treated as an EDTA-based metalloprotease inhibitor or used without checking DMSO compatibility.
-
Trypsin as a Translational Protease Design Lever
2026-09-18
Trypsin is more than a routine protein digestion enzyme: its defined cleavage preference creates a controllable entry point into protease signaling, cell biology, viral membrane fusion, and translational assay design. This article connects mechanistic rigor with practical guidance for using Trypsin (BA5744) in cell proliferation and differentiation, wound healing research, neurogenic inflammation, and PDCoV studies.
-
Obeticholic Acid: A Translational FXR Playbook
2026-09-18
Obeticholic Acid offers translational researchers a mechanistically defined way to interrogate FXR signaling across bile acid regulation, hepatic inflammation, fibrosis, and vascular physiology. This thought-leadership article connects FXR biology with recent 11β-HSD1 findings, outlines practical validation workflows, and frames how to distinguish pathway evidence from therapeutic overinterpretation.